Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research results from University of Reina Sofia update knowledge of breast cancer
August 21st, 2008
According to recent research from Cordoba, Spain, "The development of new anti-tumour drugs without clear cytoreductive activity has necessitated changes in the design of clinical trials. Defining the ''time'' parameter has become the essential objective of the majority of these trials." "However, in breast cancer, this parameter is highly variable and, as such, difficult to quantify. We developed a useful tool that takes into account the inter-relatedness of all the variables known to have the capacity to predict the time-to-progression (TTP) in advanced breast cancer. From the Alamo database (GEICAM), we selected 1798 patients diagnosed as having metastatic breast...
Source: Women's Health Weekly (2008-08-21)
|
